Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot arm aims for bullseye in abdominal cancer procedures

NCT ID NCT05529979

Knowledge-focused Sponsor: Quantum Surgical Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a robotic device that helps doctors place needles precisely into abdominal tumors. Fifty-five adults with abdominal cancer took part. The goal was to see if the robot could guide the needle accurately enough to perform the planned procedure, and to track any adjustments needed. The study did not test a new treatment, but rather gathered information on the device's performance and safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

55 people

The number who actually took part.

Started

Apr 2022

Finished

Apr 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients treated/operated in routine practice, in accordance with the device's intended use, without any additional nor burdensome procedure.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient \>18 years old, * Patient for whom a CT-guided procedure in abdomen has been prescribed and agreed by a multidisciplinary team of radiologists, surgeons and clinicians, * Patient with a confirmed non-opposition. Exclusion Criteria: * Patient unable to undergo general anesthesia, * Pregnant or breast-feeding females

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer abdomen are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer abdomen

Contacts and locations

Locations

  • Gustave Roussy Institut

    Villejuif, 94000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.